Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Potent Na+/H+ exchange inhibitor TY-12533 displays excellent cardioprotective profile in vivo

Oct. 18, 2000

Preliminary human safety and PK/PD findings reported for Z-13752A

Oct. 18, 2000

Second gene therapy product from Collateral advances to clinical testing

Oct. 16, 2000

Roche presents recently identified endothelin receptor antagonists

Oct. 13, 2000

PI-88's novel mechanism of action revealed; compound enters two new trials

Oct. 10, 2000

Natural compound improves hypertension

Oct. 9, 2000

Myogen to use SBIR grant for cardiac hypertrophy drug discovery

Oct. 9, 2000

Gene therapy trial for blocked coronary arteries commenced by Genzyme Surgical Products

Oct. 6, 2000

Initial phase I study of AC-3056 completed by Amylin

Oct. 4, 2000

Bosentan begins FDA approval process for pulmonary hypertension

Oct. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.